Clinical trial

Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis

NCT00103974

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-07-01

PhasePHASE1

Study timeline

Study start (unknown)2004-07-01Date precision: month

Registry last updated2008-04-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

BHT-3009-01BIOLOGICAL

Sponsors & collaborators

Bayhill Therapeuticslead sponsor

Mapped research locations

Los AngelesCalifornia, United States1 MontrealQuebec, Canada1 PhoenixArizona, United States1 VancouverBritish Columbia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00103974 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.